​

Funding Round

Series C - Transcarent

Series C - Transcarent

Investment Firm

Overview

Transcarent is a provider of a healthcare platform that facilitates improved outcomes and cost-effective decisions.

Announced Date

Jan 11, 2022

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

Kinnevik

Kinnevik

Kinnevik is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Human Capital

Human Capital

Human Capital is a early_stage_venture and late_stage_venture and seed firm.

Participant Investors

13

Investor Name
Participant InvestorIntermountain Healthcare
Participant Investor7wire Ventures
Participant InvestorGreatPoint Ventures
Participant InvestorThreshold
Participant InvestorGeneral Catalyst

Round Details and Background

Transcarent raised $200000000 on 2022-01-11 in Series C

Transcarent is a provider of a healthcare platform that facilitates improved outcomes and cost-effective decisions.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 10, 2021
Series B - Transcarent
9-58.0M
Oct 22, 2020
Series A - Transcarent
4-40.0M
Jan 11, 2022
Series C - Transcarent
14-200.0M
May 02, 2024
Series D - Transcarent
11-126.0M

Recent Activity

There is no recent news or activity for this profile.